N/A
Completed N=102
Medication Adherence in Rheumatic Diseases
Chronic Rheumatic Diseases
Source: ClinicalTrials.gov NCT06018350 ↗
Enrolled (actual)
102
Serious AEs
0.0%
Results posted
Sep 2025
Primary outcomePrimary: Intervention Feasibility as Measured by Number of Providers Agreeing to Participate — 6 Participants
Summary
The investigators will pilot test a clinician-led intervention to improve medication adherence in general rheumatology clinic across a spectrum of rheumatic diseases. The study will assess feasibility, acceptability, and fidelity, and explore signal for improved medication adherence.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Intervention Feasibility as Measured by Number of Providers Agreeing to Participate |
6 | — |
| PRIMARY Intervention Feasibility as Measured by the Feasibility of Intervention Measure (FIM) |
4.60 | — |
| PRIMARY Intervention Feasibility as Measured by Percent of Visits With EMR Documentation of Providers Reviewing Refills |
65.0 | — |
| SECONDARY Intervention Acceptability as Measured by the Acceptability of Intervention Measure (AIM) |
4.30 | — |
| SECONDARY Intervention Acceptability as Measured by the Percentage of Patients Who Report a Positive Feeling After Having an Adherence Conversation With Their Providers |
90.0 | — |
| SECONDARY Fidelity as Measured by the Number of Participants With Clinicians Conducting the Intervention Components of Reviewing Pharmacy Refills and Using Effective Communication Strategies |
62 | — |
| SECONDARY Fidelity as Measured by the Number of Participants With EMR Documentation of Completing the Intervention Components of Reviewing Pharmacy Refills and Using Effective Communication Strategies |
62 | — |
| SECONDARY Change in MPR (Medication Possession Ratio) as a Percentage for the Entire Sample |
11.0 | 0.002 sig |
Eligibility Criteria
Inclusion Criteria
- all providers at Southpoint Rheumatology All patients with a rheumatic disease diagnosis currently prescribed at least one rheumatic medication will be included in the analysis
Exclusion Criteria
- new patients, those who are not prescribed any rheumatic disease medications, or do not have available pharmacy refill data
Data sourced from ClinicalTrials.gov (NCT06018350). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.